Cargando…

Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review

Codeletion of chromosomal arms 1p and 19q, in conjunction with a mutation in the isocitrate dehydrogenase 1 or 2 gene, is the molecular diagnostic criterion for oligodendroglioma, IDH mutant and 1p/19q codeleted. 1p/19q codeletion is a diagnostic marker and allows prognostication and prediction of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandner, Sebastian, McAleenan, Alexandra, Jones, Hayley E., Kernohan, Ashleigh, Robinson, Tomos, Schmidt, Lena, Dawson, Sarah, Kelly, Claire, Leal, Emmelyn Spencer, Faulkner, Claire L., Palmer, Abigail, Wragg, Christopher, Jefferies, Sarah, Vale, Luke, Higgins, Julian P. T., Kurian, Kathreena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208578/ https://www.ncbi.nlm.nih.gov/pubmed/34958131 http://dx.doi.org/10.1111/nan.12790

Ejemplares similares

MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review
por: Brandner, Sebastian, et al.
Publicado: (2021)

Incorporating economic methods into Cochrane systematic reviews: case studies in brain tumour research
por: Kernohan, Ashleigh, et al.
Publicado: (2023)

Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review
por: Andrews, Lily J, et al.
Publicado: (2021)

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
por: Ducray, François, et al.
Publicado: (2008)

Case report: Spinal drop metastasis of IDH-mutant, 1p/19q-codeleted oligodendroglioma
por: Karaman, Ahmet Kursat, et al.
Publicado: (2022)

Use of Mendelian Randomization for Identifying Risk Factors for Brain Tumors
por: Howell, Amy Elizabeth, et al.
Publicado: (2018)

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021)

Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database
por: Zreik, Jad, et al.
Publicado: (2021)

Treating oligodendroglioma – An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort
por: Allwohn, Luisa, et al.
Publicado: (2023)

CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas
por: Ahn, Ju Won, et al.
Publicado: (2020)

Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
por: Merchant, Mythili, et al.
Publicado: (2022)

Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
por: Burgy, Mickaël, et al.
Publicado: (2019)

A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
por: Gilhodes, Julia, et al.
Publicado: (2023)

Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts
por: Lee, Julieann, et al.
Publicado: (2018)

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review
por: Shimizu, Hiroyuki, et al.
Publicado: (2020)

Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis
por: Robles, Luke A., et al.
Publicado: (2022)

BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum
por: Faulkner, Claire, et al.
Publicado: (2015)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014)

Oligodendroglioma in childhood.
por: Wang, K. C., et al.
Publicado: (1993)

Imaging of oligodendroglioma
por: Smits, Marion
Publicado: (2016)

Correction: Ahn, J.W., et al. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas. Cancers 2020, 12, 2543
por: Ahn, Ju Won, et al.
Publicado: (2021)

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Orozco Leal, Giovany, et al.
Publicado: (2023)

Pediatric brainstem oligodendroglioma
por: Mohindra, Sandeep, et al.
Publicado: (2012)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
por: Habiba, Umma, et al.
Publicado: (2021)

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
por: Cheng, Hung-Yuan, et al.
Publicado: (2022)

The value of dementia care towards the end of life—A contingent valuation study
por: Bhattarai, Nawaraj, et al.
Publicado: (2020)

User experiences of evidence-based online resources for health professionals: User testing of The Cochrane Library
por: Rosenbaum, Sarah E, et al.
Publicado: (2008)

Multicystic oligodendroglioma with calvarial destruction
por: Bajaj, Ajay
Publicado: (2014)

Oligodendroglioma presenting as chronic mania
por: SAHA, Rahul, et al.
Publicado: (2015)

Osteosclerosis Secondary to Metastatic Oligodendroglioma
por: Maloney, Patrick R., et al.
Publicado: (2017)

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016)

Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis
por: Cheng, Hung-Yuan, et al.
Publicado: (2020)

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
por: Li, Yan-Xi, et al.
Publicado: (2016)

CONCENTRIC LAMINATION OF GLIAL PROCESSES IN OLIGODENDROGLIOMAS
por: Robertson, David M., et al.
Publicado: (1962)

Oligodendroglioma Arising in Mature Cystic Teratoma
por: Ünal, Betül, et al.
Publicado: (2014)

Multiple Sclerosis and Oligodendroglioma: An Exceptional Association
por: Carvalho, Ana Teresa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_129bd121oc8sc64so96792htct